** Berenberg says while investors seem to find it
challenging to buy into less liquid stocks in the current market
environment, it sees some attractive value opportunities
** Following its Copenhagen Top Picks DACH Seminar 2019, it
highlights Germany-based companies Dermapharm DMPG.DE , Medios
ILM1k.DE and Stemmer Imaging S9I.DE
** It has "buy" recommendations on all three companies,
citing their solid results and attractive valuations with a good
short-term outlook
** Berenberg says Dermapharm is one of its top picks for H2
this year, adding it continues to gain market share despite
competition from Aristo
** It says it sees Stemmer's business model as intact,
saying its unique knowledge of the combination of hardware
remains difficult for competitors to replicate
** Berenberg also has a "buy" recommendation on Cyan
CYR.DE , where the rollout of its product with Orange
urn:newsml:reuters.com:*:nEQbj6nmpa is progressing nicely, the broker said urn:newsml:reuters.com:*:nFWN24801D
** It also mentions Technotrans TTRGn.DE ("buy"), a
Germany-based provider of liquid cooling technologies and
solutions, saying management was confident that the H2 upturn
needed to reach recently lowered guidance is achievable
((r.plantera@thomsonreuters.com))